Emergency Alerts in the UK will be sent where there is a risk to life in a defined area and the public must take immediate action. In the case of the recent activation regarding wildfires this was requested by the National Fire Chiefs Council, and the Alert content and broadcast area was coordinated between government and responding public bodies.

Each request is evaluated by the Cabinet Office on a rigorous, case-by-case basis to ensure it is necessary for public safety. While we strive to use this tool sparingly, the Cabinet Office remains committed to reviewing every alert request with the utmost care to balance public awareness with the potential for public fatigue. The Department conducts internal evaluation after each deployment of the capability and is committed to continuously improving this valuable service to keep people safe.

As the first step in delivering the expansion of specialty training posts by up to 4,500 in England over the next three years, more than 350 additional places were made available in August, with the aim of them starting in February 2027. To deliver this, and the remaining additional places due for 2027, the Government asked trusts to submit expressions of interest based on identified service needs, training capacity and training quality. As part of this process, it is expected that trusts assess their capacity and resources to deliver these posts, making better use of existing temporary staffing expenditure, for example on locum, bank and agency spend to convert these into substantive training posts.

The measures announced by the Foreign Secretary on 8 September will include restrictions on the import into the UK of goods originating in illegal settlements. These measures will be carefully designed to target trade with illegal settlements, while protecting legitimate trade between the UK and ‘Green Line’ Israel, including medicines and medical products. The current assessment is that the potential impact on the medicines supply chain will be low, but we will continue to monitor this following the announcement of the measures, in line with the standard process when introducing new Statutory Instruments.

Detailed guidance will be published alongside the implementing legislation to clarify the implications for UK businesses, and we will work closely with industry partners to maintain the medical supply trade and ensure continuity of supply to UK patients.

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.

The 10-Year Health Plan commits that by the end of this Parliament, we will introduce mandatory healthier food sales reporting for all large companies in the sector. We will also introduce new targets to increase the healthiness of sales.

We intend to launch a full public consultation soon to gather a wide range of views on our policy proposals. Final decisions on policy design and implementation will be taken following consultation.

No assessment has been made of the potential impact of postal delays on the timely delivery of referral letters between primary and secondary care. The monitoring of National Health Service patient correspondence, including appointment letters, is the responsibility of individual NHS providers.

We are streamlining information and communication processes, shifting from analogue to digital, including by improving the NHS App. This will make it easier and quicker for patients to access information about their appointments, to cancel and reschedule appointments, and to receive correspondence on NHS test results.

All acute trusts in England now allow patients to view appointment information via the NHS App if they wish, reducing reliance on physical letters. This saves staff time to focus on providing high quality, non-digital communication for those who want and need it. NHS App usage has increased, with over 41.6 million all-time NHS App account registrations up to the end of May 2026, 10% more than at May 2025.

No assessment has been made of the potential impact of postal delays on the timely delivery of referral letters between primary and secondary care. The monitoring of National Health Service patient correspondence, including appointment letters, is the responsibility of individual NHS providers.

We are streamlining information and communication processes, shifting from analogue to digital, including by improving the NHS App. This will make it easier and quicker for patients to access information about their appointments, to cancel and reschedule appointments, and to receive correspondence on NHS test results.

All acute trusts in England now allow patients to view appointment information via the NHS App if they wish, reducing reliance on physical letters. This saves staff time to focus on providing high quality, non-digital communication for those who want and need it. NHS App usage has increased, with over 41.6 million all-time NHS App account registrations up to the end of May 2026, 10% more than at May 2025.

Teplizumab is a new treatment for people aged eight years old and over with stage 2 type 1 diabetes, before the onset of symptoms. Its introduction represents a significant development in the treatment of type 1 diabetes and requires new clinical pathways and service arrangements to support safe and equitable access.

NHS England is working with integrated care boards, clinicians, patient groups, charities, and industry partners to support the development of these pathways. This work is already underway and is focused on helping local systems prepare for implementation and supporting consistent access across the country.

Evidence considered by the National Institute for Health and Care Excellence indicates that teplizumab can delay progression to stage 3 type 1 diabetes by almost three years on average. This gives people and their families additional time to understand the condition, prepare for future treatment and monitoring needs, and engage with clinical support before symptoms develop. Earlier identification and planned clinical management may help reduce the risk of diabetic ketoacidosis at diagnosis.

Integrated care boards will be required to make teplizumab available to all eligible individuals within the statutory 90 day implementation period. NHS England will continue to provide national leadership, including through a community of practice to share learning, support implementation, and ensure that health inequalities are identified and addressed appropriately.

The delays to Royal Mail delivery have not had an impact on DWPs ability to deliver its services. DWP has robust plans in place that will be invoked should disruption to service occur, these plans include extension of DWP deadlines that can be invoked to ensure our customers are not impacted negatively.

The delays to Royal Mail delivery have not had an impact on DWPs ability to deliver its services. DWP has robust plans in place that will be invoked should disruption to service occur, these plans include extension of DWP deadlines that can be invoked to ensure our customers are not impacted negatively.

The delays to Royal Mail delivery have not had an impact on DWPs ability to deliver its services. DWP has robust plans in place that will be invoked should disruption to service occur, these plans include extension of DWP deadlines that can be invoked to ensure our customers are not impacted negatively.

The Driver and Vehicle Licensing Agency (DVLA) is not aware of any delays by the Royal Mail that are adversely impacting the delivery of the DVLA’s mail.

Any processes which may be time bound already factor in delivery timescales to allow individuals sufficient time to respond ahead of any deadline. Where there is evidence of a severe delay, the DVLA would consider the case on its own merits. The DVLA would also consider any mitigation where it was appropriate to do so.

The Department delivers research into type 1 diabetes through the National Institute for Health and Care Research (NIHR).

As well as funding research itself, the Department invests significantly in centres of excellence which support and deliver health and care research. Collectively these form the NIHR infrastructure.

NIHR infrastructure supports research to help accelerate the development of treatments for type 1 diabetes. This includes, for example, research into earlier diagnosis and improved risk prediction to identify people who may benefit from disease-modifying or beta cell-preserving therapies. It also includes support for the development and testing of beta cell replacement, stem cell-derived islet, and immune-modulating therapies.

The NIHR infrastructure provides the end-to-end system needed to design, test, and deliver new therapies, playing a central role in delivery of clinical trials and ensuring that effective innovations are supported into practice at scale.

The NIHR is also supporting a new United Kingdom-wide Type 1 Diabetes Cell Therapy Clinical Trials Network. Funded by the Type 1 Diabetes Grand Challenge, this £5 million NIHR-backed programme aims to build a nationwide infrastructure across NIHR Biomedical Research Centres and Clinical Research Facilities for cell-therapy trials. This network is designed to address shared challenges in delivering cell therapy trials, ensuring all people with the condition gain access to the latest cutting-edge treatments as early as possible.

No specific assessment has been made on the potential merits of a multi-year funding arrangement for specialist social care provision supporting the Armed Forces community.

Local authorities are best placed to understand and plan for the needs of their population, and this would include members of the armed forces community, which is why, under the Care Act 2014, they are tasked with the duty to shape their care market to meet the diverse needs of all local people. This includes encouraging a variety of different providers and specialist services, so as to provide genuine choice to meet the range of needs and reasonable preferences of local people.

At the 2026/27 Local Government Finance Settlement, published earlier this year, the Government set out the first multi-year settlement in a decade. Running from 2026/27 to 2028/29, this enables local authorities to plan effectively on a multi-year basis.